Serum erythropoietin level in anemic cancer patients

Medical Oncology

Volumn 17, Issue 1, 2000, Pages 29-34

  Ozguroglu, Mustafa ^a,c   Arun, B ^b   Demir, G ^a   Demirelli, F ^a   Mandel, N M ^a   Buyukunal, E ^a   Serdengecti, S ^a   Berkarda, B ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Yogurtcu Basi sok Akcira apt 20/3 ^*  (Turkey)

Author keywords

Anemia; Cancer; Erythropoietin; Iron deficiency

Indexed keywords

CISPLATIN; ERYTHROPOIETIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0034016393     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02826213     Document Type: Article

References (23)

1. 1 Aglietta M. Diagnostic approach to the anemic cancer patient. Tumori 1997; 83 (4): S20-S25.
2. 2 Cartwright GE. The anemia of chronic disorders. Semin Haematol 1966; 3: 351-375.
3. 3 Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
4. 4 Heiss MM et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867.
5. 5 Thomas ML. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin. Med Oncol 1998; 15 (Suppl 1): S13-S18.
6. 6 Graber SE, Krantz SB. Erythropoietin and the control of red cell production. Ann Rev Med 1978; 29: 51-66.
7. 7 Spivak JL. Serum immunoreactive erythropoietin in health and disease. J Perinat Med 1995; 23: 13-17.
8. 8 Zucker S, Friedman S, Lysik RM. Bone marrow erytropoiesis in the anemia of infection, inflammation and malignancy. J Clin Invest 1974; 53: 1132-1138.
9. 9 Schreuder WO, Ting WC, Smith S, Jacobs A. Testosterone, erythropoietin, and anemia in patients with disseminated bronchial cancer. Br J Haematol 1984; 57: 521-526.
10. 10 Cox R, Musial T, Gyde OHB. Reduced erythropoietin levels as a cause of anemia in patients with lung cancer. Eur J Cancer Clin Oncol. 1986; 22: 511-514.
11. 11 Miller JB, Jones RJ, Piontadosi S, Abeloff M, Spivak JL. Decreased erythropietin response in patients with the anemia of cancer. N Engl J Med 1990; 322(24): 1689-1692.
12. 12 Nowrousian MR et al. Pathophysiology of cancer-related anemia. In: JF Smyth, MA Boogaerts, BRM Ehmer (eds.). rhErythropoietin in Cancer Supportive Treatment 1996; pp 13-34.
13. 13 Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639-1647.
14. 14 Joosten E et al. Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia. J Am Geriatr Soc 1993; 41(12): 1301-1304.
15. 15 Honda K et al. Anemia-inducing substance from plasma of patients with advanced malignant neoplasms. Cancer Res 1995; 55: 3623-3628.
16. 16 Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 1994; 68: 215-223.
17. 17 Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998; 3 (Suppl 7): 2-6.
18. 18 Birgegard G, Wide L, Simonsson B. Marked erythropoietin increase before fall in hemoglobin after treatment with cytostatic drugs suggest mechanism other than anemia for stimulation. Br J Haematol 1989; 72: 462-466.
19. 19 Hasegawa I, Tanaka K. Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy. Gynecol Oncol 1992; 46(1): 65-68.
20. 20 Shamseddine A et al. The relation between erythropoietin, hematocrit, and hemoglobin in breast cancer patients on non-nephrotoxic chemotherapy. Eur J Gynaecol Oncol 1998; 19(6): 577-579.
21. 21 Wood P, Nygaand S, Hrushesky WJM. Cisplatin induced anemia is correctable with erythropoietin. Blood 1988; 72 (Suppl): 52 (Abstract).
22. 22 Saijo Y et al. Changes in serum erythropoietin levels during chemotherapy for lung cancer. Chemotherapy 1992; 38(5): 281-285.
23. 23 Beguin Y. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer. Med Oncol 1998; 15 (Suppl 1): S38-S46.